Clinical Trials Logo

Filter by:
NCT ID: NCT03972839 Completed - Clinical trials for Blood Coagulation Disorder

Comparison of Two D-Dimers Dosing Techniques

COMPADDI
Start date: July 1, 2019
Phase:
Study type: Observational

Study of the possibility of substitution of the automated STAGO D-Dimers method with the semi-automated VIDAS method, which is more expensive, longer to implement and requires the use of a dedicated automaton.

NCT ID: NCT03972423 Completed - Anesthesia Clinical Trials

Impact of a Transmission Checklist in Post Anesthesia Care Unit on Immediate Respiratory Complications

TC-IRC
Start date: February 18, 2019
Phase:
Study type: Observational [Patient Registry]

This work highlighted the beneficial role in terms of carers' satisfaction, quantity and quality of information transmitted.

NCT ID: NCT03971994 Completed - Alzheimer Disease Clinical Trials

Emotion and Attention in Alzheimer's Disease (ATEMMA)

ATEMMA
Start date: May 31, 2019
Phase: N/A
Study type: Interventional

The main purpose of this study is to investigate the existence of emotional attention impairments in Alzheimer's Disease, in correlation with amygdala and attention networks alterations. To this end, functional and structural neuroimaging will be used. A face expression recognition task, along with eyetracking, will be used to assess emotional attention impairments.

NCT ID: NCT03971877 Completed - Clinical trials for Colistin Resistance in Bacteria

Detection of Colistin-resistant Isolates From Patients of Intensive Care Units and Oncohaematology Wards.

RESCO
Start date: December 16, 2019
Phase:
Study type: Observational

The increasing use of colistin in multidrug resistant strains, as Enterobacteriaceae producing extended-spectrum β-lactamases or carbapenemases, is associated with the emergence of colistin resistant isolates. The main objective of this project is to estimate the diagnostic accuracy (sensitivity and specificity) of a new rapid detection test of colistin resistant strains (Rapid Polymyxin NP test) isolated in clinical settings.

NCT ID: NCT03971513 Completed - Surgery Clinical Trials

Trans Abdominal Plane Block (TAP Block) in Surgery of Stoma Reversal and Its Effect on Post Operative Recovery: a Prospective, Randomized, Muticenter Study

Tapas
Start date: June 17, 2019
Phase: N/A
Study type: Interventional

The primary purpose of TAPAS study is to demonstrate the superiority of analgesic effect of trans abdominal plane block (TAP block) performed at the beginning of stoma reversal, compared to standard of care. The hypothesize is that a TAP block performed at the beginning of surgery of stoma reversal would improve patient's satisfaction (evaluated by Quo-r40 questionnaire), would reduce the incidence of post operative pain, time spent in recovery room, and reduce hospitalisation time

NCT ID: NCT03971422 Completed - Clinical trials for Generalized Myasthenia Gravis

A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis

Start date: June 3, 2019
Phase: Phase 3
Study type: Interventional

The purpose of the MycarinGstudy is to demonstrate the clinical efficacy and to assess safety and tolerability of rozanolixizumab in patients with generalized myasthenia gravis (MG).

NCT ID: NCT03971071 Completed - Migraine Headache Clinical Trials

A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache

Start date: October 7, 2019
Phase: Phase 4
Study type: Interventional

Study 20170703 is a phase 4, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of erenumab against placebo in participants with chronic migraine (CM) who have a history of at least 1 preventive treatment failure and are diagnosed with medication overuse headache (MOH).

NCT ID: NCT03970954 Completed - Clinical trials for Recurrent Miscarriage

Low-dose Interleukin-2 in Women With Unexplained Miscarriages

FaCIL-2
Start date: January 5, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to demonstrate the ability of low dose IL-2 to stimulate peripheral blood Tregs of women with unexplained repeated early spontaneous miscarriages for development of a therapy to prevent fetal rejection by low dose IL-2.

NCT ID: NCT03970915 Completed - Hypothermia Clinical Trials

Warm-up Efficiency by Body Warmer Versus Standard Procedure in Severely Traumatized Patients

THERMOTRAUMA
Start date: October 17, 2019
Phase: N/A
Study type: Interventional

Study of adult patients with severe all-cause trauma having a body temperature less than 36°Celsius (C) that is managed by a Mobile Emergency Service team and oriented towards a Vital Emergency Room. Currently two devices are used to warm patients during their care at the scene of an accident: a survival blanket and heating in the emergency vehicle. Despite these two devices many patients arrive in hypothermia (body temperature less than 36°C) in emergency departments. The objective of this study is to evaluate the effectiveness of a body warmer associated with standard warming devices on the correction of hypothermia compared to the standard procedure in severely traumatized patients with hypothermia . It is a national multicentric study with 14 participating Mobile Emergency Service centers and hopefully will include 612 patients. The study will be carried out according to a pattern of 28 successive periods of one week each during the winter period (October to April), for a total duration of 7 months. 14 action periods ON (warming standard procedure + body warmer) and 14 control periods OFF (warming standard procedure) will be run in random order for each center.

NCT ID: NCT03970785 Completed - Clinical trials for Surgical Procedure, Unspecified

Intraoperative Fluorescence of Ganglogliomas and Neuroepithelial Dysembryoplastic Tumors

FLUOGOD
Start date: July 15, 2018
Phase:
Study type: Observational

One of the key issues of tumour brain surgeries is to clearly define the borders of the tumor. The investigators proposed to evaluate the feasibility of intraoperative fluorescein guidance. Patients will be identified from the list of patients operated on under fluorescence to collect clinical datas. Surgical videos will be analyzed to assess the presence of intraoperative fluorescence and its subjectively judged intensity. MRI data will be extracted from the radiological reports to assess quality extraction. No additional data will be produced